Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahasweta Gooptu

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Transplantation and Cellular Therapy|November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor AllograftJessica S Little, Rémy Duléry, Roman M Shapiro, et al.
Blood Advances|February 9, 2021
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experienceKatie Maurer, Anna Saucier, Haesook T Kim, et al.
Transplantation and Cellular Therapy|May 19, 2026
Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice GuidelinesZachariah DeFilipp, Amin Alousi, John E Levine, et al.
Blood Advances|January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamideBenedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
Blood Advances|September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemiaHaesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Bone Marrow Transplantation|September 8, 2020
Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host diseaseNatasha Kekre, Haesook T Kim, Julia Hofer, et al.
Transplantation and Cellular Therapy|March 21, 2026
Impact of Post-Transplant Cyclophosphamide on the Prognostic Value of HCT-CIAnsh Mehta, Haesook T Kim, Arcita Pramudita, et al.
Transplantation and Cellular Therapy|September 23, 2025
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell TransplantationJessica S Little, Kyle M Hebert, Donna S Neuberg, et al.
Haematologica|April 29, 2022
Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantationBenedetta Rambaldi, Haesook T Kim, Yohei Arihara, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Transplantation and Cellular Therapy|November 20, 2023
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor AllograftJessica S Little, Rémy Duléry, Roman M Shapiro, et al.
Blood Advances|February 9, 2021
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experienceKatie Maurer, Anna Saucier, Haesook T Kim, et al.
Transplantation and Cellular Therapy|May 19, 2026
Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice GuidelinesZachariah DeFilipp, Amin Alousi, John E Levine, et al.
Blood Advances|January 26, 2021
Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamideBenedetta Rambaldi, Haesook T Kim, Carol Reynolds, et al.
Blood Advances|September 4, 2020
Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemiaHaesook T Kim, Conner J Shaughnessy, Sharmila C Rai, et al.
Bone Marrow Transplantation|September 8, 2020
Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host diseaseNatasha Kekre, Haesook T Kim, Julia Hofer, et al.
Transplantation and Cellular Therapy|March 21, 2026
Impact of Post-Transplant Cyclophosphamide on the Prognostic Value of HCT-CIAnsh Mehta, Haesook T Kim, Arcita Pramudita, et al.
Transplantation and Cellular Therapy|September 23, 2025
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell TransplantationJessica S Little, Kyle M Hebert, Donna S Neuberg, et al.
Haematologica|April 29, 2022
Phenotypic and functional characterization of the CD6-ALCAM T-cell co-stimulatory pathway after allogeneic cell transplantationBenedetta Rambaldi, Haesook T Kim, Yohei Arihara, et al.
Pageof 7